|
![]() |
|||
|
||||
OverviewFull Product DetailsAuthor: Mark K. FergusonPublisher: Springer London Ltd Imprint: Springer London Ltd Edition: 2nd ed. 2011 Dimensions: Width: 17.80cm , Height: 2.80cm , Length: 25.40cm Weight: 1.126kg ISBN: 9781849963640ISBN 10: 1849963649 Pages: 526 Publication Date: 07 January 2011 Audience: Professional and scholarly , Professional & Vocational Format: Hardback Publisher's Status: Active Availability: Awaiting stock ![]() The supplier is currently out of stock of this item. It will be ordered for you and placed on backorder. Once it does come back in stock, we will ship it out for you. Table of ContentsReviewsFrom the reviews of the second edition: This textbook deals with the staging (TNM), surgical management (open lobectomy vs. VATS lobectomy), the chemoradiotherapy, and other therapies for most forms of lung cancer. It does a good job. ... The current literature on lung carcinoma is well described and discussed. I would definitely recommend this book to physicians, oncologists, and CVT surgeons. (Joseph J. Grenier, Amazon.com, September, 2013) Author InformationMark K. Ferguson, MD is Professor of Surgery at University of Chicago Medical Center. He specializes in the surgical management of diseases of the lungs and esophagus. He is experienced in all techniques of lung and esophageal resection, and is skilled in surgical methods to relieve airway obstruction and malignant pleural effusions. He has served on the boards and committees of numerous national societies and institutions including the Food and Drug Administration (FDA) and the National Institutes of Health. Dr. Ferguson is the author of more than 75 chapters in medical textbooks. He has edited or written books on esophageal reconstructive surgery, failed anti-reflux therapy, and decision-making in thoracic surgery. He recently authored an atlas of general thoracic surgery. Dr. Ferguson has also written more than 175 papers in medical journals, and serves as an editor or associate editor for three cardiothoracic surgery journals. His research interests include risk analysis and long-term outcomes after lung resection and esophageal resection. Tab Content 6Author Website:Countries AvailableAll regions |